3p0g
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Structure of a nanobody-stabilized active state of the beta2 adrenoceptor== | ==Structure of a nanobody-stabilized active state of the beta2 adrenoceptor== | ||
- | <StructureSection load='3p0g' size='340' side='right' caption='[[3p0g]], [[Resolution|resolution]] 3.50Å' scene=''> | + | <StructureSection load='3p0g' size='340' side='right'caption='[[3p0g]], [[Resolution|resolution]] 3.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3p0g]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3p0g]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Camelus_glama Camelus glama] and [https://en.wikipedia.org/wiki/Human Human]. The April 2011 RCSB PDB [https://pdb.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/index.html Molecule of the Month] feature on ''Nanobodies'' by David Goodsell is [https://dx.doi.org/10.2210/rcsb_pdb/mom_2011_4 10.2210/rcsb_pdb/mom_2011_4]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3P0G OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3P0G FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P0G:8-[(1R)-2-{[1,1-DIMETHYL-2-(2-METHYLPHENYL)ETHYL]AMINO}-1-HYDROXYETHYL]-5-HYDROXY-2H-1,4-BENZOXAZIN-3(4H)-ONE'>P0G</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=P0G:8-[(1R)-2-{[1,1-DIMETHYL-2-(2-METHYLPHENYL)ETHYL]AMINO}-1-HYDROXYETHYL]-5-HYDROXY-2H-1,4-BENZOXAZIN-3(4H)-ONE'>P0G</scene></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR, E ([ | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR, E ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
- | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3p0g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3p0g OCA], [https://pdbe.org/3p0g PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3p0g RCSB], [https://www.ebi.ac.uk/pdbsum/3p0g PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3p0g ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/ADRB2_HUMAN ADRB2_HUMAN]] Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 22: | ||
==See Also== | ==See Also== | ||
+ | *[[Adrenergic receptor 3D structures|Adrenergic receptor 3D structures]] | ||
+ | *[[Antibody 3D structures|Antibody 3D structures]] | ||
*[[Lysozyme 3D structures|Lysozyme 3D structures]] | *[[Lysozyme 3D structures|Lysozyme 3D structures]] | ||
- | *[[3D structures of antibody|3D structures of antibody]] | + | *[[3D structures of non-human antibody|3D structures of non-human antibody]] |
== References == | == References == | ||
<references/> | <references/> | ||
Line 30: | Line 32: | ||
[[Category: Camelus glama]] | [[Category: Camelus glama]] | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Nanobodies]] | [[Category: Nanobodies]] |
Revision as of 11:06, 18 May 2022
Structure of a nanobody-stabilized active state of the beta2 adrenoceptor
|
Categories: Camelus glama | Human | Large Structures | Lysozyme | Nanobodies | RCSB PDB Molecule of the Month | Casarosa, P | Chae, P S | Choi, H J | DeVree, B T | Fung, J J | Gellman, S H | Kobilka, B K | Kobilka, T S | Konetzki, I | Pardon, E | Pautsch, A | Rasmussen, S G.F | Rosenbaum, D M | Schnapp, A | Steyaert, J | Sunahara, R K | Thian, F S | Weis, W I | Agonist | Beta-2 adrenoceptor | Gpcr | Hydrolase | Membrane | Membrane protein | Nanobody | Signaling protein